News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts:
Classifieds |
Jobs |
Business
-
Briefly
Suven Life ties up with Eli Lilly
HYDERABAD:
The Hyderabad-based Suven Life Sciences on Tuesday announced the signing of an agreement with Eli Lilly and Company, a U.S.-based global pharmaceutical firm, to collaborate on the pre-clinical research of molecules in the therapeutic area of central nervous system (CNS) disorders. Ramakrishna Nirogi, Vice President, Drug Discovery, Suven, said scientists from both companies would work together with the goal of identifying potent oral compounds that selectively modulate the specified "G- Protein Coupled Receptor" for the target CNS disease. Venkat Jasti, Vice Chairman and CEO of Suven, said the collaboration would help the company realise the next step of its strategic vision.
Printer friendly
page
Send this article to Friends by
E-Mail
Business
News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts:
Classifieds |
Jobs |
Updates:
Breaking News |
|
